In this study, we show, for the first time, that there were significant differences in EFS when comparing standard and low risk subgroups of paediatric AML patients (p = 0.02) and when comparing patients across both subgroups with the lowest and highest quartile expression levels of BIRC5 (p = 0.03). Here, BIRC5 is linked to acute myeloid leukemia.